Description

7-Benzyl-3-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine is a high-purity, advanced pharmaceutical intermediate characterized by its unique fused heterocyclic structure. This compound is of significant value in medicinal chemistry for its role as a versatile synthetic building block in the development of novel active pharmaceutical ingredients (APIs). It is primarily sought after by research institutions and pharmaceutical manufacturers engaged in the synthesis of complex molecules targeting central nervous system (CNS) disorders and other therapeutic areas.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of potent drug candidates, particularly those with imidazopyrazine scaffolds.
• Medicinal Chemistry Research: Used extensively in lead optimization and structure-activity relationship (SAR) studies to develop new therapeutic agents.
• CNS Drug Development: Serves as a key building block for compounds targeting neurological receptors and enzymes.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for clinical trial materials.
• Academic Research: Utilized in university and institutional labs for studying heterocyclic chemistry and novel synthetic methodologies.
• Bioconjugation & Probe Synthesis: The reactive bromo substituent allows for further functionalization, making it useful for creating chemical probes and labeled compounds.

Basic Information

Product Name	7-Benzyl-3-Bromo-5,6,7,8-Tetrahydroimidazo[1,5-a]Pyrazine
CAS No.	601515-08-6
Molecular Formula	C₁₃H₁₄BrN₃
Molecular Weight	292.18 g/mol
Synonyms	3-Bromo-7-benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 7-Benzyl-3-bromo-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine; Imidazo[1,5-a]pyrazine, 3-bromo-7-benzyl-5,6,7,8-tetrahydro-; 601515-08-6; 3-Bromo-7-benzyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 7-Benzyl-3-bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine; 3-Bromo-7-phenylmethyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine
EINECS	Contact for details

Quality Control

Our 7-Benzyl-3-Bromo-5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research and development applications. All products undergo rigorous analytical testing, including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles is provided with each shipment to support your quality assurance protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to minimize exposure to moisture. Incompatible with strong acids and oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Related Substances (HPLC)	Total impurities ≤ 3.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.